CMS to begin audits for schizophrenia coding, says citations will affect quality ratings
By
Alicia Lasek
Jan 19, 2023
The agency will start auditing nursing homes this month to determine whether residents’ schizophrenia diagnoses are accurate and appropriately coded. A pattern of inaccurate coding may result in a quality...
‘Unfair’ posting of disputed citations will tarnish operators: experts
By
Kimberly Marselas
Jan 19, 2023
The decision to post disputed nursing home citations on a government website for consumers riled providers and legal experts Wednesday.
CMS, OIG agree on increasing scrutiny of psychotropic drug use
By
Joe Bush
Nov 18, 2022
The Centers for Medicare & Medicaid Services will be increasing its oversight of the use of psychotropic drugs to pay closer attention to certain classes, warned the lead author of a federal report identifying...
Feds’ antipsychotics program fails to reduce prescriptions in assisted living
By
Alicia Lasek
Aug 23, 2022
In a federal initiative to reduce unnecessary antipsychotics prescribing, results in assisted living didn’t match the successes seen in nursing homes, a new study reveals.
Use of common hospice drugs varies widely by state, highlighting limited guidance
By
Alicia Lasek
Aug 16, 2022
Antipsychotics prescribing rates, for example, ranged from 62% for hospice beneficiaries in Oregon to 15% in Oklahoma, investigators say. Five states topped the prescriptions list.
F-tags study reveals common misuses of psychotropic drugs in LTC
By
Alicia Lasek (f3)
May 13, 2022
A study of deficiency-of-care citations in nursing homes offers lessons on reducing over-reliance on psychotropics in residents with dementia, investigators say.
Pandemic bump in antipsychotics use raises questions about long-term care outcomes
By
Danielle Brown
Apr 12, 2022
The findings raise questions about the short- and long-term effects on the quality of care and health outcomes for residents, the authors say.
Rise in antipsychotics prescriptions during pandemic warrant closer look, feds say
By
Danielle Brown
Apr 11, 2022
A federal study has found that prescriptions for antipsychotic medication in nursing homes and assisted living facilities increased by 7.4% during the first quarter, or first three months, of the pandemic.
The importance of informed consent in antipsychotic regulations
By
Karen Robson
Mar 16, 2022
Informed consent is not consistently interpreted in regards to the use of drugs such as antipsychotics in nursing home residents with dementia.
Antipsychotic medication reduction and the severely mentally ill population
By
Eleanor Feldman Barbera, Ph.D.
Mar 08, 2022
President Biden’s State of the Union address last week targeted several aspects of the long-term care industry, most of which have received more attention than his mention of reducing the inappropriate...